The Relation of Cigarette Smoking to Incident Alzheimer’s Disease in a Biracial Urban Community Population
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The relationship between smoking status and incident Alzheimer’s disease (AD) was investigated in a random stratified sample of a biracial community in Chicago. Analyses are based on 1,064 persons (of 1,134 evaluated) who had data on smoking status, disease incidence, and key covariates such as apolipoprotein allele status. During a mean of about 4 years of follow-up, 170 persons met criteria for incident AD. Current smoking was associated with increased risk of incident AD (OR = 3.4, 95% CI = 1.4–8.0) compared to persons who never smoked. There was no apparent increase in risk of AD for former smokers compared to persons who never smoked (OR = 0.9, 95% CI = 0.5–1.7). Apolipoprotein E allele status modified this association in that former smokers with a υ4 allele were less likely to develop AD (p = 0.04) than those who never smoked. Former smokers also appeared to have a reduced risk of developing AD as their pack-years of smoking increased (p = 0.02)such that the odds of developing AD increased by 50% for every 10 years of smoking cessation (OR = 1.3, CI = 0.9–1.7). The results suggest that older people who currently smoke are more likely to develop AD compared to those who never smoked; the relation between those who used to smoke but quit and the risk of AD is complex and requires further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Self-citationRestriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678
Self-citationEvidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Cognitive activity and incident AD in a population-based sample of older persons
Wilson, R. S., Bennett, D. A., Bienias, J. L., Aggarwal, N. T., Mendes de Leon, C. F., Morris, M. C., Schneider, J. A., & Evans, D. A. (2002) · Neurology · doi:10.1212/01.wnl.0000036905.59156.a1 · Cited by 456
Self-citationEvans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370 · cited 1×
“In this study, we explored the relation of current and former cigarette smoking as well as measures of intensity (pack-years) and duration of exposure to smoking to the occurrence of incident AD in the Chicago Health and Aging Project (CHAP), a longitudinal population-based study of aging and AD in a biracial urban co…”
BackgroundSelf-citationMid-life smoking and late-life dementia: the Honolulu-Asia Aging Study
Tyas, S. L., White, L. R., Petrovitch, H., Webster Ross, G., Foley, D. J., Heimovitz, H. K., & Launer, L. J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00156-2 · Cited by 226
Cited by
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain
Swan, G. E., & Lessov-Schlaggar, C. N. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9035-9 · Cited by 580
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 451
The epidemiology of the dementias: an update
Qiu, C., De Ronchi, D., & Fratiglioni, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32816ebc7b · Cited by 418
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362
Cataldo, J. K., Prochaska, J. J., & Glantz, S. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1240 · Cited by 335
Smoking, dementia and cognitive decline in the elderly, a systematic review
Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., & Bulpitt, C. (2008) · BMC Geriatrics · doi:10.1186/1471-2318-8-36 · Cited by 333
Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia
Rusanen, M., Kivipelto, M., Quesenberry, C. P., Zhou, J., & Whitmer, R. A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.393 · Cited by 329
Chen, J.-H., Lin, K.-P., & Chen, Y.-C. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60402-2 · Cited by 288
Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science
Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R., Connolly, E. S., Dunbar-Jacob, J. M., Granieri, E. C., McGarry, K., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.100 · Cited by 252
Di Marco, L. Y., Marzo, A., Muñoz-Ruiz, M., Ikram, M. A., Kivipelto, M., Ruefenacht, D., Venneri, A., Soininen, H., Wanke, I., Ventikos, Y. A., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132225 · Cited by 215
“Similarly, in [86] current smokers at baseline were more likely to develop with never smokers.”
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
“Three studies, the Chicago Health and Aging Project (CHAP), WHICAP, and a study from Chongqing City, reported that current smoking increased the risk of incident AD.(28,49,50) An additional article from the Canadian Study of Health and Aging (CSHA) recorded only smoking and found that it was not significant.”
BackgroundAgarwal, P., Leurgans, S. E., Agrawal, S., Aggarwal, N. T., Cherian, L. J., James, B. D., Dhana, K., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2023) · Neurology · doi:10.1212/wnl.0000000000207176 · Cited by 170
Self-citationDhana, K., Franco, O. H., Ritz, E. M., Ford, C. N., Desai, P., Krueger, K. R., Holland, T. M., Dhana, A., Liu, X., Aggarwal, N. T., et al. (2022) · BMJ · doi:10.1136/bmj-2021-068390 · Cited by 164
Self-citationRole of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Walker, D., & Lue, L.-F. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793667 · Cited by 66
“Smoking is a significant risk factor for the development of AD [3,105], likely due to the effects of the many toxic components of cigarette smoke (e.”
BackgroundBlood pressure variability, dementia, and role of antihypertensive medications in older adults
Mahinrad, S., Bennett, D. A., Sorond, F. A., & Gorelick, P. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12935 · Cited by 32
Self-citationSex-specific transcriptional rewiring in the brain of Alzheimer’s disease patients
Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1009368 · Cited by 16
“GABRA1 was identified as a therapeutic target of clinical AD drugs (Aggarwal et al., 2006; Xu Y. et al., 2021).”
Background
Metadata
- Authors
- Aggarwal, N. T., Bienias, J. L., Bennett, D. A., Wilson, R. S., Morris, M. C., Schneider, J. A., Shah, R. C., & Evans, D. A.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 26
- Issue
- 3
- Pages
- 140-146
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2092403723
- Cited by
- 118
- References
- 12
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.